Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Actívatexto: Helping Latinos quit smoking and become more active

Official title: Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos

Run by University of Rochester · NCT06926608 · Data updated 2026-11-12

This trial tests whether Actívatexto, a text-message program combined with wearables and nicotine replacement, helps Latino adults who smoke quit and increase their physical activity.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment408 (estimated)
SponsorUniversity of Rochester
Academic / other
Locations1 site (Rochester, New York)
StatusRecruiting
StartedJune 17, 2025
Main results expectedMay 31, 2029
Study endsMay 31, 2029
Registry record updatedSeptember 18, 2026
Trial IDNCT06926608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Latino adults (18+) who smoke at least three days per week, want to quit within 30 days, are insufficiently active, have a text-capable cellphone, and can wear a device daily and attend study visits.

Probably not a fit

People who use non-cigarette tobacco products, are pregnant or breastfeeding, plan to move away in six months, have another household member enrolled, or cannot safely increase activity are excluded and unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-arm randomized trial enrolling 408 Latino adults who smoke and are not meeting recommended physical activity levels. Participants are randomly assigned to Actívatexto, which targets both smoking cessation and physical activity with text messages, wearable monitoring, nicotine replacement therapy, and an online dashboard, or to Decídetexto, which targets only smoking cessation. All participants receive nicotine replacement therapy and a Fitbit device, with assessments at baseline, 3 months, and 6 months. Recruitment is community-based and the research team manages incoming data from texts and wearables to support participants.

Why it matters

Potential benefit: If successful, the program could provide a scalable way to help Latino smokers quit and become more physically active, lowering their long-term health risks.

How similar studies have gone: Standalone text-messaging programs and nicotine replacement therapies have shown success for smoking cessation, but integrated text-plus-wearable interventions that also target physical activity—especially among Latinos—are less well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Self-identify as Hispanic and/or Latino
* Know how to read and speak English and/or Spanish
* Be ≥ 18 years of age
* Not meet the recommended levels of physical activity (150 minutes of moderate to vigorous physical activity)
* Smoke cigarettes at least 3 days per week
* Be interested in quitting smoking in the next 30 days
* Have a cellphone with text messaging capability
* Know how to utilize text messages
* Be willing to wear a wearable device daily to monitor physical activity
* Be willing to complete all study visits

Exclusion Criteria:

* Use of tobacco products other than cigarettes in the past 30 days (including e-cigarettes)
* Being pregnant or breastfeeding
* Plan to move from their current residence in the next six months
* Another household member enrolled in the study
* Unable to become more physically active or engage in a fitness appraisal

Where it's running

  • University of Rochester Medical Center
    Rochester, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.